Compared with the model group, the surface antigens of CD8+ TRM cells in the APS group increased significantly (p < 0.05), suggesting that APS induced the production of CD8+ TRM cells in vivo. The gene discussed is CD8A; the disease is autoimmune polyendocrinopathy.